CRISPR/Cas9 for hepatitis B virus infection treatment
Bo Cai, Shixue Chang, Yuhan Tian, Shuai Zhen • Immunity, Inflammation and Disease
(2023)
Abstract Hepatitis B virus (HBV) infection remains a global health challenge. Despite the availability of effective preventive vaccines, millions of people are at risk of cirrhosis and hepatocellular carcinoma. Current drug therapies inhibi...
DOAJ
Open Access (DOAJ)
DOI:
10.1002/iid3.866